v3.26.1
ACQUISITIONS - Schedule of Recognized Asset Acquired and Liability Assumed (Details) - USD ($)
$ in Thousands
Jun. 30, 2026
Apr. 27, 2026
Dec. 31, 2025
[1]
Business Combination [Line Items]      
Goodwill $ 655,745   $ 196,199
Amicus Therapeutics      
Business Combination [Line Items]      
Cash and cash equivalents   $ 255,931  
Accounts receivable, net   123,912  
Inventory   469,700  
Other current assets   55,052  
Property, plant and equipment   25,923  
Intangible assets   4,750,000  
Goodwill   459,164  
Other assets   59,219  
Accounts payable and accrued liabilities   (205,466)  
Deferred tax liabilities   (565,050)  
Other long-term liabilities   (104,824)  
Total assets and liabilities   $ 5,323,561  
[1]
(1)December 31, 2025 balances were derived from the audited Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on February 26, 2026.